The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies.

Wiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LMJ. · 2021

Read The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies. by Wiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LMJ. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8001875.txt.

Introduction

Wiertsema and co-authors present a review of the interplay between gut microbes and the immune system in infection. Infections still kill many people in poor countries and threaten the very young and old everywhere. The gut holds 70–80% of the body's immune cells. Its microbes, lining, and local defences form one tight system. That system also steers immunity across the whole body, the authors stress.

The review explains how the balance among microbes, gut health, and immunity is kept. It links that balance to infections at each stage of life. Nutrition runs through the account as a lever. What a person eats shapes both the microbes and the immune response. Clinicians already use that knowledge in care. The authors argue food should sit inside plans to prevent and treat infection, not beside them.

Catalog record

CREATORWiertsema SP, van Bergenhenegouwen J, Garssen J, Knippels LMJ.
YEAR2021
COLLECTIONPAPERS
FORMATTXT
FILE SIZE67 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC8001875

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

The Interplay between the Gut Microbiome and the Immune System in the Context of Infectious Diseases throughout Life and the Role of Nutrition in Optimizing Treatment Strategies By Selma P Wiertsema, Jeroen van Bergenhenegouwen, Johan Garssen, Leon M J Knippels, Amedeo Amedei, Maurizio Battino Published in: Nutrients DOI: 10.3390/nu13030886 ABSTRACT Abstract Infectious diseases and infections remain a leading cause of death in low-income countries and a major risk to vulnerable groups, such as infants and the elderly. The immune system plays a crucial role in the susceptibility, persistence, and clearance of these infections. With 70–80% of immune cells being present in the gut, there is an intricate interplay between the intestinal microbiota, the intestinal epithelial layer, and the local mucosal immune system. In addition to the local mucosal immune responses in the gut, it is increasingly recognized that the gut microbiome also affects systemic immunity. Clinicians are more and more using the increased knowledge about these complex interactions between the immune system, the gut microbiome, and human pathogens. The now well-recognized impact of nutrition on the composition of the gut microbiota and the immune system elucidates the role nutrition can play in improving health. This review describes the mechanisms involved in maintaining the intricate balance between the microbiota, gut health, the local immune response, and systemic immunity, linking this to infectious diseases throughout life, and highlights the impact of nutrition in infectious disease prevention and treatment. Keywords: infectious diseases, microbiome, gut health, mucosal immunity, systemic immunity, nutrition 1. INFECTIONS In the Western world, the incidence of infectious diseases has reduced significantly during the past decades owing to improved hygiene, vaccination, and the use of antibiotics [1]. In the developing world, however, nearly one-third of deaths are still associated with infectious diseases. In addition, infections still pose a significant risk for vulnerable people, such as infants and the elderly. Upper respiratory tract infections are the most common disease for which individuals seek medical care and, in elderly people, both influenza and pneumonia are still a common cause of death [1]. The World Health Organization states that infectious enteric disease is one of the main causes of death and, according to the Global Burden of Diseases, Injuries, and Risk Factors Study of 2015, infectious diarrhea is a major cause of death worldwide, with a large percentage of these deaths occurring in the under 5 age group [2,3]. 2. PROTECTION FROM INFECTIONS IN THE GASTRO-INTESTINAL TRACT: THE GUT MICROBIOTA AND EPITHELIAL BARRIER There are three main hurdles that pathogens need to overcome to cause an infection in the gastro-intestinal (GI) tract: the intestinal microbiota, the intestinal epithelial layer, and the mucosal immune system [4]. The gut microbiota consists of a multispecies microbial community, consisting of bacteria, fungi, and viruses, living within a particular niche in synergy with the host [5]. Gut microbes and mammals have coevolved, so while microbes get a habitat to florish, the microbes regulate various host physiological functions, including regulating protective immunity against pathogens [6]. The composition of the gut microbiota is influenced by many factors, such as genetics; gender; age; socio-economic factors; nutrition; stress; and environmental factors, such as pollutants, antibiotics, and others—the so-called exposome [7]. Factors that disturb the microbial community structure and function, like the use of antibiotics, give space to opportunistic pathogens to colonize, grow, and persist [8]. There are several mechanisms in which the microbiota ensures the prevention of colonization, overgrowth, pathogen-induced damage, and subsequent infection of the host. One mechanism is referred to as colonization resistance, where the commensal microbiota and invading microorganisms compete for resource availability, or niche opportunity, either in terms of nutritional or functional space [8,9,10]. To allow for this competition, bacterial cells continuously sense the environment using signaling molecules accumulated during bacterial replication, in that way monitoring population density and adjusting their gene expression accordingly, a mechanism called quorum sensing [5,11]. The chemical signals lead to phenotypic changes of the bacteria that are associated with adherence, motility, and intestinal density, or with the excretion of protective compounds. The quorum sensing mechanism is used by commensals to ensure gut homeostasis, but is also used by pathogens to minimize host immune responses and increase pathogenicity [4]. Alterations to microbiota community structure, or a non-beneficial microbiota composition, potentially induced by diet, stress, and antibiotic and drug treatment, change the overall dynamics between the microbiota and host to result in low-grade inflammation, reduced colonization resistance, and altered infection susceptibility [12]. Next to the gut microbiota, the gut epithelial barrier plays a crucial role in protecting the host from infections by pathogens [13]. This physical barrier that separates the commensal bacteria in the gut from the underlying tissues is a monolayer of cells joined through tight-junction-protein complexes. The assembly of tight-junction complexes is a dynamic process, which can be disrupted by certain bacteria through the release of toxins [8]. In addition, the epithelial cell layer is reinforced by a layer of mucus. This mucus lining of the epithelial barrier is among the first defense mechanisms of the intestinal epithelia against bacterial invasion, by preventing luminal and mucosal microbes from directly interacting with epithelial cells [4]. In addition to its function as a biophysical barrier, mucus also acts as a reservoir for host-produced antimicrobial molecules such as secretory IgA and defensins [14]. Mucus production and degradation are governed via an intricate interaction between host and microbes regulated through host recognition of microbe-associated molecular patterns (MAMPs) and bacterial metabolites, and are thus susceptible to changes in the composition of the indigenous microbiota [15]. Between mucus and microbes exists a reciprocal relationship where both changes in the host inflammatory state and changes in the microbiota composition can contribute to alterations in mucus production and composition, leading to increased susceptibility to infection [16]. The continuous interaction between the gut microbiota and intestinal epithelium leads to constant immune signaling [17]. Regulation of this immune response, together with epithelial barrier integrity and permeability in the presence of commensal bacteria and invading pathogens, is essential for the maintenance of intestinal homeostasis. If this process is impaired, it can result in inflammation and infection. 3. PROTECTION FROM INFECTIONS: INTERACTION BETWEEN THE GUT MICROBIOTA AND THE LOCAL IMMUNE SYSTEM The immune response plays a crucial role in the susceptibility to and persistence and clearance of infections. The immune system is comprised of two parts: the innate immune system and the adaptive immune system [18]. The innate immune system provides nonspecific protection by several defense mechanisms, which include physical barriers such as the skin and mucous membranes; chemical barriers like enzymes and antimicrobial proteins; and innate immune cells including granulocytes, macrophages, and natural killer cells [19]. The cells of the adaptive immune system, T- and B-lymphocytes, recognize and respond to specific foreign antigens. T cells recognize infectious agents that have entered into host cells. This type of adaptive immunity depends on the direct involvement of cells and is, therefore, referred to as cellular immunity. In addition, T cells play an important role in regulating the function of B cells that secrete antibodies and proteins that recognize specific antigens. Because antibodies circulate through the humours (i.e., body fluids), the protection induced by B cells is termed humoral immunity [20]. Development of the immune system and efficacy

Read the complete text